Company name:

Portola Pharmaceuticals Inc

  • IPO SHARE PRICE:
    $14.00
  • IPO DATE:
    May 22, 2013
  • TICKER:
    PTLA
  • MAIN STOCK EXCHANGE:
    NASDAQ
  • CURRENT HQ LOCATION:
    270 E Grand Avenue South San Francisco California 94080
  • FISCAL YEAR END:
    December 31
  • INCORPORATION JURISDICTION:
    DE
  • ORGANIZED AS THE FOLLOWING LEGAL TYPE:
    Corporation
  • Investor Relations Webpage:
    Coming soon!
  • TAX RATE:
    USA federal corporate nominal income tax rate is 21%

Short Description

Portola Pharmaceuticals Inc

We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com

Income Statement

Quarterly Annual
(USD in thousand)
Selected Quarter:
31-Mar
2020
Revenue
Gross receipts in the form of cash (great!) and promises to pay (Account Receivables - not so great as some of them will never be collected but reality of business!) from all its customers
100%
97.2% —

Product revenue

2.8% —

Collaboration and license revenue
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
Product revenue
-
-
-
-
-
-
-
-
45,679
45,679
45,679
-
45,679
 2,265 7,176 14,070 20,362 27,164 35,743 28,375 25,637 116,919 102,548
Collaboration and license revenue
-
-
-
-
-
-
-
-
$45,679
$45,679
$45,679
$45,679
$45,679
 1,746 7,001 1,228 1,807 1,260 1,056 873 752 3,941 3,008
Total Revenue
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 $4,011 $14,177 $15,298 $22,169 $28,424 $36,799 $29,248 $26,389 $120,860 $105,556
Selected Quarter:
31-Mar
2020
Operating expenses
Cost (labor, materials, depreciation, overhead, etc) for delivering service or manufacturing a product that business sells
321.4%
206.2% —

Selling general and administrative

98.9% —

Research and development

16.4% —

Cost of sales
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
Cost of sales
-
-
-
-
-
-
45,679
-
45,679
45,679
45,679
-
45,679
 1,052 4,292 12,401 7,150 4,991 2,684 29,553 4,320 41,548 17,280
Research and development
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
 66,440 40,237 49,461 35,584 33,538 25,647 29,858 26,089 115,132 104,356
Selling general and administrative
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
 40,214 38,792 40,617 53,034 53,855 52,050 59,980 54,418 220,303 217,672
Total operating expenses
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
 $107,706 $83,321 $102,479 $95,768 $92,384 $80,381 $119,391 $84,827 $376,983 $339,308
Selected Quarter:
31-Mar
2020
Operating Income
Income after excluding Operating Expenses from Total Revenue
221.4%
221.4% —

Operating Income

Key metric that shows earnings potential of the company's business model
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
Operating income
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 ($103,695) ($69,144) ($87,181) ($73,599) ($63,960) ($43,582) ($90,143) ($58,438) ($256,123) ($233,752)
Selected Quarter:
31-Mar
2020
Non-operating expenses
Cost usually unrelated to delivering service or manufacturing a product that business sells
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
Total non-operating income (expense)
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
 - - - - - - - - - -
Selected Quarter:
31-Mar
2020
Earnings before Interest and Taxes (EBIT)
Income after excluding Operating and Non-operating Expenses from Total Revenue
221.4%
221.4% —

EBIT

Another income metric but unlike Operating Income it is closer to the ultimate income metric - Net Income by removing expenses that are not related to earning Revenue as they are supposed to be accidental and transitory
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
EBIT
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 ($103,695) ($69,144) ($87,181) ($73,599) ($63,960) ($43,582) ($90,143) ($58,438) ($256,123) ($233,752)
Selected Quarter:
31-Mar
2020
Interest Expense and Income, Taxes
Expenses driven mostly by company management's choices, nature of business (capital intensive vs not) about financing (debt vs equity) and legal structure
39.2%
8.3% —

Interest and other income or expenses

30.9% —

Interest expense
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
Interest expense
-
-
-
-
45,679
45,679
45,679
-
45,679
45,679
45,679
45,679
45,679
 (4,104) (5,957) (6,098) (6,481) (8,538) (7,998) (8,273) (8,147) (32,956) (32,588)
Interest and other income or expenses
45,679
45,679
-
-
-
45,679
45,679
45,679
-
45,679
-
-
-
 - - - 1,984 - - - (2,186) (2,186) (8,744)
Interest and other income TEST - ODD
-
-
45,679
-
45,679
-
-
-
45,679
-
45,679
-
45,679
 1,828 3,924 - 1,984 4,021 1,953 - - 5,974 -
Selected Quarter:
31-Mar
2020
Net income (loss)
Ultimate measure of Income - Net result after excluding all expenses from Total Revenue
260.6%
260.6% —

Net income (loss)

It is a residue that is left from Total Revenue after paying all kind of expenses and belongs to all equity holders in the company. Some of these shareholders such Non-controlling interest or Preferred equity gets their share before Common shareholders
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net income (loss)
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 ($105,971) ($71,177) ($88,886) ($78,096) ($68,477) ($49,627) ($96,676) ($68,771) ($283,551) ($275,084)
Net income (loss) attributable to non-controlling interests Net income (loss) attributable to non-controlling interests
45,679
45,679
45,679
-
45,679
45,679
45,679
-
45,679
45,679
45,679
45,679
45,679
 (223) (126) 338 (60) 2,273 - - - 2,273 -
Net income (loss) attributable to Company
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
45,679
 (106,194) (71,303) (88,548) (78,156) (66,204) (49,627) (96,676) (68,771) (281,278) (275,084)

Basic Shares Outstanding
Basic shares outstanding as of certain dates reported by Company on its annual and quarterly filings, these numbers are NOT used calculation of basic EPS. They help to see share issuance by company in perspective
Common
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
45,678,795
 66,085,536 66,434,026 66,821,167 68,109,684 68,323,733 77,819,156 78,080,365 78,483,617 78,483,617 78,483,617
Selected Quarter:
31-Mar
2020
EPS
Net Income / Shares Outstanding = EPS before dilution or Basic EPS; Net Income/ ( Shares Outstanding + potentially available shares from conversion of various option instruments)
Selected Quarter:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net Income per basic share
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
 ($1.61) ($1.08) ($1.34) ($1.17) ($0.97) ($0.68) ($1.27) ($0.88) $219,317,156.20 ($3.52)
Net Income per diluted share
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
 ($1.61) ($1.08) ($1.34) ($1.17) ($0.97) ($0.68) ($1.27) ($0.88) $219,317,156.20 ($3.52)